Selected research
Industry Research
Lab-on-a-chip and Microarrays (BIOCHIP) Industry Research Report 2026
Market perspective
The global Lab-on-a-chip and Microarrays (BIOCHIP) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lab-on-a-chip and Microarrays (BIOCHIP) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lab-on-a-chip and Microarrays (BIOCHIP) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lab-on-a-chip and Microarrays (BIOCHIP) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lab-on-a-chip and Microarrays (BIOCHIP) include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lab-on-a-chip and Microarrays (BIOCHIP) market in revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Lab-on-a-chip and Microarrays (BIOCHIP).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lab-on-a-chip and Microarrays (BIOCHIP) Market by Company
Abbott Laboratories
Agilent Technologies
Bio-Rad Laboratories
Beckman Coulter
Cepheid
Fluidigm
GE Healthcare
Roche Holding
Illumina
Biomerieux
Thermo Fisher Scientific
PerkinElmer
Lab-on-a-chip and Microarrays (BIOCHIP) Segment by Type
DNA Microarrays
Microfluidics
Lab-on-a-chip and Microarrays (BIOCHIP) Segment by Application
Genomics
Proteomics
Cell Assays
Clinical Diagnostics
Drug Discovery
Others
Lab-on-a-chip and Microarrays (BIOCHIP) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lab-on-a-chip and Microarrays (BIOCHIP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lab-on-a-chip and Microarrays (BIOCHIP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lab-on-a-chip and Microarrays (BIOCHIP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lab-on-a-chip and Microarrays (BIOCHIP) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lab-on-a-chip and Microarrays (BIOCHIP) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lab-on-a-chip and Microarrays (BIOCHIP) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Microarrays
- Microfluidics
Applications
- Genomics
- Proteomics
- Cell Assays
- Clinical Diagnostics
- Drug Discovery
- Others
Companies covered
- Abbott Laboratories
- Agilent Technologies
- Bio-Rad Laboratories
- Beckman Coulter
- Cepheid
- Fluidigm
- GE Healthcare
- Roche Holding
- Illumina
- Biomerieux
- Thermo Fisher Scientific
- PerkinElmer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Lab-on-a-chip and Microarrays (BIOCHIP) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 DNA Microarrays
- 2.2.3 Microfluidics
- 2.3 Lab-on-a-chip and Microarrays (BIOCHIP) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Genomics
- 2.3.3 Proteomics
- 2.3.4 Cell Assays
- 2.3.5 Clinical Diagnostics
- 2.3.6 Drug Discovery
- 2.3.7 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Manufacturers (2021-2026)
- 3.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Manufacturers (2021-2026)
- 3.3 Global Lab-on-a-chip and Microarrays (BIOCHIP) Average Price by Manufacturers (2021-2026)
- 3.4 Global Lab-on-a-chip and Microarrays (BIOCHIP) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lab-on-a-chip and Microarrays (BIOCHIP) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Lab-on-a-chip and Microarrays (BIOCHIP) Manufacturers, Product Type & Application
- 3.7 Global Lab-on-a-chip and Microarrays (BIOCHIP) Manufacturers Established Date
- 3.8 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.1.2 Abbott Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.1.3 Abbott Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Agilent Technologies
- 4.2.1 Agilent Technologies Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.2.2 Agilent Technologies Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.2.3 Agilent Technologies Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.2.4 Agilent Technologies Product Portfolio
- 4.2.5 Agilent Technologies Recent Developments
- 4.3 Bio-Rad Laboratories
- 4.3.1 Bio-Rad Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.3.2 Bio-Rad Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.3.3 Bio-Rad Laboratories Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.3.4 Bio-Rad Laboratories Product Portfolio
- 4.3.5 Bio-Rad Laboratories Recent Developments
- 4.4 Beckman Coulter
- 4.4.1 Beckman Coulter Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.4.2 Beckman Coulter Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.4.3 Beckman Coulter Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.4.4 Beckman Coulter Product Portfolio
- 4.4.5 Beckman Coulter Recent Developments
- 4.5 Cepheid
- 4.5.1 Cepheid Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.5.2 Cepheid Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.5.3 Cepheid Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.5.4 Cepheid Product Portfolio
- 4.5.5 Cepheid Recent Developments
- 4.6 Fluidigm
- 4.6.1 Fluidigm Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.6.2 Fluidigm Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.6.3 Fluidigm Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.6.4 Fluidigm Product Portfolio
- 4.6.5 Fluidigm Recent Developments
- 4.7 GE Healthcare
- 4.7.1 GE Healthcare Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.7.2 GE Healthcare Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.7.3 GE Healthcare Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.7.4 GE Healthcare Product Portfolio
- 4.7.5 GE Healthcare Recent Developments
- 4.8 Roche Holding
- 4.8.1 Roche Holding Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.8.2 Roche Holding Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.8.3 Roche Holding Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.8.4 Roche Holding Product Portfolio
- 4.8.5 Roche Holding Recent Developments
- 4.9 Illumina
- 4.9.1 Illumina Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.9.2 Illumina Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.9.3 Illumina Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.9.4 Illumina Product Portfolio
- 4.9.5 Illumina Recent Developments
- 4.10 Biomerieux
- 4.10.1 Biomerieux Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.10.2 Biomerieux Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.10.3 Biomerieux Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.10.4 Biomerieux Product Portfolio
- 4.10.5 Biomerieux Recent Developments
- 4.11 Thermo Fisher Scientific
- 4.11.1 Thermo Fisher Scientific Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.11.2 Thermo Fisher Scientific Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.11.3 Thermo Fisher Scientific Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.11.4 Thermo Fisher Scientific Product Portfolio
- 4.11.5 Thermo Fisher Scientific Recent Developments
- 4.12 PerkinElmer
- 4.12.1 PerkinElmer Lab-on-a-chip and Microarrays (BIOCHIP) Company Information
- 4.12.2 PerkinElmer Lab-on-a-chip and Microarrays (BIOCHIP) Business Overview
- 4.12.3 PerkinElmer Lab-on-a-chip and Microarrays (BIOCHIP) Production, Value and Gross Margin (2021-2026)
- 4.12.4 PerkinElmer Product Portfolio
- 4.12.5 PerkinElmer Recent Developments
5 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Region
- 5.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Region: 2021-2032
- 5.2.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Region: 2021-2026
- 5.2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Forecast by Region (2027-2032)
- 5.3 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Region: 2021-2032
- 5.4.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Region: 2021-2026
- 5.4.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Forecast by Region (2027-2032)
- 5.5 Global Lab-on-a-chip and Microarrays (BIOCHIP) Market Price Analysis by Region (2021-2026)
- 5.6 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production and Value, YOY Growth
- 5.6.1 North America Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts (2021-2032)
- 5.6.5 South Korea Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Estimates and Forecasts (2021-2032)
6 Global Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Region
- 6.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Region (2021-2032)
- 6.2.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Region: 2021-2026
- 6.2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lab-on-a-chip and Microarrays (BIOCHIP) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lab-on-a-chip and Microarrays (BIOCHIP) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Lab-on-a-chip and Microarrays (BIOCHIP) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Lab-on-a-chip and Microarrays (BIOCHIP) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Type (2021-2032)
- 7.1.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Type (2021-2032) & (k units)
- 7.1.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Market Share by Type (2021-2032)
- 7.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Type (2021-2032)
- 7.2.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Market Share by Type (2021-2032)
- 7.3 Global Lab-on-a-chip and Microarrays (BIOCHIP) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Application (2021-2032)
- 8.1.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production by Application (2021-2032) & (k units)
- 8.1.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Market Share by Application (2021-2032)
- 8.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Application (2021-2032)
- 8.2.1 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Lab-on-a-chip and Microarrays (BIOCHIP) Production Value Market Share by Application (2021-2032)
- 8.3 Global Lab-on-a-chip and Microarrays (BIOCHIP) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Lab-on-a-chip and Microarrays (BIOCHIP) Value Chain Analysis
- 9.1.1 Lab-on-a-chip and Microarrays (BIOCHIP) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Lab-on-a-chip and Microarrays (BIOCHIP) Production Mode & Process
- 9.2 Lab-on-a-chip and Microarrays (BIOCHIP) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lab-on-a-chip and Microarrays (BIOCHIP) Distributors
- 9.2.3 Lab-on-a-chip and Microarrays (BIOCHIP) Customers
10 Global Lab-on-a-chip and Microarrays (BIOCHIP) Analyzing Market Dynamics
- 10.1 Lab-on-a-chip and Microarrays (BIOCHIP) Industry Trends
- 10.2 Lab-on-a-chip and Microarrays (BIOCHIP) Industry Drivers
- 10.3 Lab-on-a-chip and Microarrays (BIOCHIP) Industry Opportunities and Challenges
- 10.4 Lab-on-a-chip and Microarrays (BIOCHIP) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst